Titre : Vascularite

Vascularite : Questions médicales fréquentes

Termes MeSH sélectionnés :

Communication Barriers

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une vascularite ?

Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie.
Vascularite Biopsie Imagerie médicale
#2

Quels tests sanguins sont utilisés ?

Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants.
Tests sanguins Inflammation Vitesse de sédimentation
#3

Quels symptômes indiquent une vascularite ?

Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées.
Symptômes Fatigue Éruption cutanée
#4

La biopsie est-elle toujours nécessaire ?

Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants.
Biopsie Diagnostic Vascularite
#5

Quels spécialistes consultent pour une vascularite ?

Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic.
Rhumatologie Médecine interne Vascularite

Symptômes 5

#1

Quels sont les symptômes courants de la vascularite ?

Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées.
Symptômes Fatigue Éruption cutanée
#2

La vascularite peut-elle causer des douleurs articulaires ?

Oui, les douleurs articulaires sont fréquentes et peuvent être sévères.
Douleurs articulaires Vascularite Symptômes
#3

Y a-t-il des symptômes neurologiques associés ?

Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir.
Symptômes neurologiques Vascularite Engourdissement
#4

Les éruptions cutanées sont-elles spécifiques ?

Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura.
Éruption cutanée Purpura Vascularite
#5

La vascularite peut-elle affecter les organes internes ?

Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications.
Organes internes Complications Vascularite

Prévention 5

#1

Peut-on prévenir la vascularite ?

Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide.
Prévention Suivi médical Vascularite
#2

Les vaccinations sont-elles recommandées ?

Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite.
Vaccination Prévention Infections
#3

Comment éviter les déclencheurs ?

Éviter le tabac, le stress et les infections peut réduire les risques de poussées.
Déclencheurs Prévention Vascularite
#4

Le suivi médical est-il important ?

Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes.
Suivi médical Vascularite Traitement
#5

Y a-t-il des conseils diététiques ?

Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire.
Alimentation Antioxydants Vascularite

Traitements 5

#1

Quels traitements sont disponibles pour la vascularite ?

Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés.
Corticostéroïdes Immunosuppresseurs Traitement
#2

Les corticostéroïdes sont-ils efficaces ?

Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement.
Corticostéroïdes Inflammation Vascularite
#3

Quand utilise-t-on des immunosuppresseurs ?

Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes.
Immunosuppresseurs Vascularite Traitement
#4

Y a-t-il des traitements alternatifs ?

Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques.
Thérapies biologiques Vascularite Traitement
#5

Le traitement est-il à long terme ?

Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois.
Traitement Vascularite Suivi médical

Complications 5

#1

Quelles sont les complications possibles de la vascularite ?

Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques.
Complications Lésions organiques Vascularite
#2

La vascularite peut-elle entraîner des problèmes rénaux ?

Oui, elle peut causer une insuffisance rénale aiguë ou chronique.
Insuffisance rénale Complications Vascularite
#3

Quels risques cardiovasculaires sont associés ?

Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC.
Risques cardiovasculaires AVC Vascularite
#4

Les complications sont-elles réversibles ?

Certaines complications peuvent être réversibles avec un traitement précoce.
Complications Traitement Vascularite
#5

Comment surveiller les complications ?

Des examens réguliers et des tests de fonction organique sont essentiels.
Surveillance Examens médicaux Vascularite

Facteurs de risque 5

#1

Quels sont les facteurs de risque de la vascularite ?

Les facteurs incluent des antécédents familiaux, des infections et certains médicaments.
Facteurs de risque Antécédents familiaux Vascularite
#2

L'âge influence-t-il le risque de vascularite ?

Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées.
Âge Facteurs de risque Vascularite
#3

Les infections peuvent-elles déclencher une vascularite ?

Oui, des infections virales ou bactériennes peuvent être des déclencheurs.
Infections Déclencheurs Vascularite
#4

Le tabagisme est-il un facteur de risque ?

Oui, le tabagisme est associé à un risque accru de vascularite.
Tabagisme Facteurs de risque Vascularite
#5

Certaines maladies auto-immunes augmentent-elles le risque ?

Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque.
Maladies auto-immunes Facteurs de risque Vascularite
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vascularite : Questions médicales les plus fréquentes", "headline": "Vascularite : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vascularite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-06", "dateModified": "2025-03-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vascularite" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies vasculaires", "url": "https://questionsmedicales.fr/mesh/D014652", "about": { "@type": "MedicalCondition", "name": "Maladies vasculaires", "code": { "@type": "MedicalCode", "code": "D014652", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aortite", "alternateName": "Aortitis", "url": "https://questionsmedicales.fr/mesh/D001025", "about": { "@type": "MedicalCondition", "name": "Aortite", "code": { "@type": "MedicalCode", "code": "D001025", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.080" } } }, { "@type": "MedicalWebPage", "name": "Artérite", "alternateName": "Arteritis", "url": "https://questionsmedicales.fr/mesh/D001167", "about": { "@type": "MedicalCondition", "name": "Artérite", "code": { "@type": "MedicalCode", "code": "D001167", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.090" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Endartérite", "alternateName": "Endarteritis", "url": "https://questionsmedicales.fr/mesh/D004692", "about": { "@type": "MedicalCondition", "name": "Endartérite", "code": { "@type": "MedicalCode", "code": "D004692", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.090.340" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndrome de Cogan", "alternateName": "Cogan Syndrome", "url": "https://questionsmedicales.fr/mesh/D055952", "about": { "@type": "MedicalCondition", "name": "Syndrome de Cogan", "code": { "@type": "MedicalCode", "code": "D055952", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.320" } } }, { "@type": "MedicalWebPage", "name": "Phlébite", "alternateName": "Phlebitis", "url": "https://questionsmedicales.fr/mesh/D010689", "about": { "@type": "MedicalCondition", "name": "Phlébite", "code": { "@type": "MedicalCode", "code": "D010689", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thrombophlébite", "alternateName": "Thrombophlebitis", "url": "https://questionsmedicales.fr/mesh/D013924", "about": { "@type": "MedicalCondition", "name": "Thrombophlébite", "code": { "@type": "MedicalCode", "code": "D013924", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740.910" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de Lemierre", "alternateName": "Lemierre Syndrome", "url": "https://questionsmedicales.fr/mesh/D057831", "about": { "@type": "MedicalCondition", "name": "Syndrome de Lemierre", "code": { "@type": "MedicalCode", "code": "D057831", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740.910.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndrome de Lemierre", "alternateName": "Lemierre Syndrome", "url": "https://questionsmedicales.fr/mesh/D057831", "about": { "@type": "MedicalCondition", "name": "Syndrome de Lemierre", "code": { "@type": "MedicalCode", "code": "D057831", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740.910.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vascularite rétinienne", "alternateName": "Retinal Vasculitis", "url": "https://questionsmedicales.fr/mesh/D031300", "about": { "@type": "MedicalCondition", "name": "Vascularite rétinienne", "code": { "@type": "MedicalCode", "code": "D031300", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.815" } } }, { "@type": "MedicalWebPage", "name": "Vascularite systémique", "alternateName": "Systemic Vasculitis", "url": "https://questionsmedicales.fr/mesh/D056647", "about": { "@type": "MedicalCondition", "name": "Vascularite systémique", "code": { "@type": "MedicalCode", "code": "D056647", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.897" } } }, { "@type": "MedicalWebPage", "name": "Thromboangéite oblitérante", "alternateName": "Thromboangiitis Obliterans", "url": "https://questionsmedicales.fr/mesh/D013919", "about": { "@type": "MedicalCondition", "name": "Thromboangéite oblitérante", "code": { "@type": "MedicalCode", "code": "D013919", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.905" } } } ], "about": { "@type": "MedicalCondition", "name": "Vascularite", "alternateName": "Vasculitis", "code": { "@type": "MedicalCode", "code": "D014657", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David S Younger", "url": "https://questionsmedicales.fr/author/David%20S%20Younger", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu." } }, { "@type": "Person", "name": "Tanaz A Kermani", "url": "https://questionsmedicales.fr/author/Tanaz%20A%20Kermani", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA." } }, { "@type": "Person", "name": "Christian Pagnoux", "url": "https://questionsmedicales.fr/author/Christian%20Pagnoux", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto." } }, { "@type": "Person", "name": "Cristina Ponte", "url": "https://questionsmedicales.fr/author/Cristina%20Ponte", "affiliation": { "@type": "Organization", "name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com." } }, { "@type": "Person", "name": "Nikita Khmelinskii", "url": "https://questionsmedicales.fr/author/Nikita%20Khmelinskii", "affiliation": { "@type": "Organization", "name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Making clear and effective communication SOuND BETTeR for patients with communication barriers.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37844910", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1742-6723.14323" } }, { "@type": "ScholarlyArticle", "name": "Perceived Communication Barriers by Caregivers of Psychiatric Patients.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37489673", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.33314/jnhrc.v20i4.4249" } }, { "@type": "ScholarlyArticle", "name": "Communication sheet eases barriers for Japanese patients and health professionals.", "datePublished": "2022-07-30", "url": "https://questionsmedicales.fr/article/35907847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-022-08371-x" } }, { "@type": "ScholarlyArticle", "name": "Can ChatGPT rescue or assist with language barriers in healthcare communication?", "datePublished": "2023-08-14", "url": "https://questionsmedicales.fr/article/37591023", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.pec.2023.107940" } }, { "@type": "ScholarlyArticle", "name": "Caring for older culturally and linguistically diverse patients with Cancer: Healthcare Providers' perceived barriers to communication.", "datePublished": "2022-05-17", "url": "https://questionsmedicales.fr/article/35589543", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jgo.2022.04.009" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Vascularite", "item": "https://questionsmedicales.fr/mesh/D014657" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vascularite - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vascularite", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vascularite", "description": "Comment diagnostiquer une vascularite ?\nQuels tests sanguins sont utilisés ?\nQuels symptômes indiquent une vascularite ?\nLa biopsie est-elle toujours nécessaire ?\nQuels spécialistes consultent pour une vascularite ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vascularite", "description": "Quels sont les symptômes courants de la vascularite ?\nLa vascularite peut-elle causer des douleurs articulaires ?\nY a-t-il des symptômes neurologiques associés ?\nLes éruptions cutanées sont-elles spécifiques ?\nLa vascularite peut-elle affecter les organes internes ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vascularite", "description": "Peut-on prévenir la vascularite ?\nLes vaccinations sont-elles recommandées ?\nComment éviter les déclencheurs ?\nLe suivi médical est-il important ?\nY a-t-il des conseils diététiques ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vascularite", "description": "Quels traitements sont disponibles pour la vascularite ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des immunosuppresseurs ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il à long terme ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vascularite", "description": "Quelles sont les complications possibles de la vascularite ?\nLa vascularite peut-elle entraîner des problèmes rénaux ?\nQuels risques cardiovasculaires sont associés ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vascularite", "description": "Quels sont les facteurs de risque de la vascularite ?\nL'âge influence-t-il le risque de vascularite ?\nLes infections peuvent-elles déclencher une vascularite ?\nLe tabagisme est-il un facteur de risque ?\nCertaines maladies auto-immunes augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Communication+Barriers#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une vascularite ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants." } }, { "@type": "Question", "name": "Quels symptômes indiquent une vascularite ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées." } }, { "@type": "Question", "name": "La biopsie est-elle toujours nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants." } }, { "@type": "Question", "name": "Quels spécialistes consultent pour une vascularite ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la vascularite ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées." } }, { "@type": "Question", "name": "La vascularite peut-elle causer des douleurs articulaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les douleurs articulaires sont fréquentes et peuvent être sévères." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir." } }, { "@type": "Question", "name": "Les éruptions cutanées sont-elles spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura." } }, { "@type": "Question", "name": "La vascularite peut-elle affecter les organes internes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications." } }, { "@type": "Question", "name": "Peut-on prévenir la vascularite ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide." } }, { "@type": "Question", "name": "Les vaccinations sont-elles recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite." } }, { "@type": "Question", "name": "Comment éviter les déclencheurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac, le stress et les infections peut réduire les risques de poussées." } }, { "@type": "Question", "name": "Le suivi médical est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des conseils diététiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la vascularite ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement." } }, { "@type": "Question", "name": "Quand utilise-t-on des immunosuppresseurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques." } }, { "@type": "Question", "name": "Le traitement est-il à long terme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la vascularite ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques." } }, { "@type": "Question", "name": "La vascularite peut-elle entraîner des problèmes rénaux ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut causer une insuffisance rénale aiguë ou chronique." } }, { "@type": "Question", "name": "Quels risques cardiovasculaires sont associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement précoce." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des tests de fonction organique sont essentiels." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la vascularite ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections et certains médicaments." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de vascularite ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Les infections peuvent-elles déclencher une vascularite ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections virales ou bactériennes peuvent être des déclencheurs." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de vascularite." } }, { "@type": "Question", "name": "Certaines maladies auto-immunes augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 03/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

David S Younger

3 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu.
Publications dans "Vascularite" :

Tanaz A Kermani

3 publications dans cette catégorie

Affiliations :
  • Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA.
Publications dans "Vascularite" :

Christian Pagnoux

3 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto.
Publications dans "Vascularite" :

Cristina Ponte

2 publications dans cette catégorie

Affiliations :
  • Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
  • Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Publications dans "Vascularite" :

Nikita Khmelinskii

2 publications dans cette catégorie

Affiliations :
  • Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
  • Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Publications dans "Vascularite" :

Dennis McGonagle

2 publications dans cette catégorie

Affiliations :
  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, Leeds, UK.
Publications dans "Vascularite" :

Elisabeth Brouwer

2 publications dans cette catégorie

Affiliations :
  • University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: e.brouwer@umcg.nl.
Publications dans "Vascularite" :

Seza Ozen

2 publications dans cette catégorie

Affiliations :
  • Division of Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Hacettepe University Vasculitis Research Center, Ankara, Turkey.
Publications dans "Vascularite" :

Paul A Monach

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publications dans "Vascularite" :

Ulrich Specks

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Publications dans "Vascularite" :

Kenneth J Warrington

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Publications dans "Vascularite" :

Peter A Merkel

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Rheumatology and Division of Clinical Epidemiology, University of Pennsylvania, Philadelphia, PA.
Publications dans "Vascularite" :

None None

2 publications dans cette catégorie

Publications dans "Vascularite" :

Hannah Cooke

2 publications dans cette catégorie

Affiliations :
  • Musgrove Park Hospital, Taunton, UK.

Matthew Wells

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK matthew.wells@nbt.nhs.uk.

Keith Miller

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK.

Andrew R L Medford

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK.

Sam Patel

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK.

Fawad Aslam

2 publications dans cette catégorie

Affiliations :
  • Mayo Clinic, Phoenix, Arizona, USA.

Mario Sestan

2 publications dans cette catégorie

Affiliations :
  • Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.

Sources (10000 au total)

Perceived Communication Barriers by Caregivers of Psychiatric Patients.

Caregivers have significant role in effective treatment and recovery during hospitalization. Communication barriers in health care lead to poor treatment outcome of patients and caregiver's dissatisfa... A cross-sectional study was conducted among 120 caregivers of psychiatric patients admitted in psychiatric ward of Patan Hospital who were selected by purposive sampling and interviewed using self-dev... Low extent of communication barrier was perceived by 29.17%, great extent by 25.83%, moderate extent by 24.17% and no barriers were perceived by 20.83% caregivers. There was association between durati... More than one fourth caregiver's perceived low extent of communication barrier, almost one fourth perceived great extent and less than one fourth perceived moderate extent. There was association betwe...

Communication sheet eases barriers for Japanese patients and health professionals.

Language and cultural barriers can affect healthcare outcomes of minority populations. However, limited data are available on communication tools developed to address health disparities resulting from... This study was conducted at a family health center in a United States urban setting, in the city of Pittsburgh, between November 2019 and August 2020. This study included Japanese adult patients who h... Sixty Japanese patients met inclusion criteria and completed the survey. More than half of participants found the JECS useful, and those with self-reported limited English proficiency were most likely... The JECS is a useful communication tool for addressing common barriers faced by Japanese patients seeking care at an American health center where Japanese-speaking physicians work but no clinic staff ...

Caring for older culturally and linguistically diverse patients with Cancer: Healthcare Providers' perceived barriers to communication.

Due to various socio-cultural and language related factors, healthcare providers experience barriers when communicating with older culturally and linguistically diverse (CALD) patients with cancer, wh... In order to lay out the healthcare providers' perceived barriers to communication, the present study identified and compared communication barriers among different healthcare providers when caring for... An online survey was conducted among healthcare providers in the Netherlands who identified as being involved in the care of CALD patients with cancer (N = 191), specifically; GPs (N... Overall, low Dutch language proficiency of older CALD patients with cancer, family interpreters providing inadequate translations, not knowing the extent of patients' informational needs, cultural dif...

Communication in refugee and migrant mental healthcare: A systematic rapid review on the needs, barriers and strategies of seekers and providers of mental health services.

Migrants and refugees may not access mental health services due to linguistic and cultural discordance between them and health and social care professionals (HSCPs). The aim of this review is to ident... We undertook a rapid systematic review of the literature (01/01/2011 - 09/03/2022) on seeking and/or providing mental health services in linguistically discordant settings. Quality appraisal was perfo... 58/5,650 papers met the inclusion criteria. Both TCNs (and their carers) and HSCPs experience difficulties when seeking or providing mental health services and language barriers are present. TCNs and ... Language barriers impede TCNs' access to mental health services. Improving language support options and cultural competency in mental health services is crucial to ensure that individuals from diverse...

Recognition of language barriers in comprehending non-communicable disease management among rural elderly people in the DIMAMO surveillance area: a case of AWI-Gen participants.

Language plays a critical role in health communication, particularly in the management and understanding of non-communicable diseases (NCDs) among elderly populations. This study aimed to explore the ... This qualitative phenomenological study was conducted with elderly participants aged 60 years and above, all of whom have chronic diseases. In-depth face-to-face interviews were conducted using an int... Five major themes emerged regarding participants' understanding of NCDs and the perceived language barriers. These include Limited Knowledge and Awareness of NCDs, Misconceptions about NCDs, Mixed per... The study revealed significant misconceptions about diabetes and hypertension, as well as traditional practices like bloodletting, which were perceived to relieve hypertension symptoms. It also identi...

How to overcome information and communication barriers in Human Papillomavirus vaccination? A SWOT analysis based on the opinions of European family doctors in contact with young people and their parents.

Family doctors (FDs)/General practitioners (GPs) are the key contact points for young people and their parents regarding Human Papillomavirus (HPV) vaccination. However, their recommendations are infl... Under the EU4Health project, PROTECT-EUROPE, WONCA Europe led a task to identify and analyse strategies for clinicians' interpersonal communication skills when discussing HPV and its vaccination with ... Strengths, Weaknesses, Opportunities, Threats (SWOT) analysis using qualitative data focused on HPV vaccine acceptance and communication with the target population. FDs/GPs, members of WONCA Europe, w... 223 FDs/GPs from 36 countries participated. Strengths included face-to-face communication, extensively used to promote the HPV vaccine. Weaknesses involved financial constraints, limited knowledge abo... It is crucial to train FDs/GPs to address knowledge gaps, enhance communication skills, and maintain a trusting relationship with patients when discussing HPV vaccination. Overcoming financial barrier...

Systemic barriers to reporting work injuries and illnesses in contexts of language barriers.

Workers who experience language barriers are at increased risk of work-related injuries and illnesses and face difficulties reporting these health problems to their employer and workers' compensation.... This study merges data from two qualitative studies that investigated experiences with workers' compensation and return-to-work, respectively, for injured workers who experience language barriers. We ... Almost all workers (34/39) had filed a claim, though most had initially delayed reporting their injuries or illnesses to their employer or to workers' compensation. Workers faced several obstacles to ... Improving the linguistic and cultural competence of organizations and their representatives is insufficient to address under-reporting among workers who experience language barriers. Efforts to improv...

Language barriers and kidney transplantation in children.

Understanding disparities in pediatric kidney transplants is important to provide equitable care. We compared transplant outcomes between English-speaking (ES) and interpreter-needing (IN) pediatric k... Through retrospective review, primary kidney transplant recipients, 0-21 years transplanted between 2005 and 2019, were divided into ES and IN cohorts. Continuous and categorical variables were compar... Our sample included 211 ES and 37 IN transplant recipients. Compared with the ES, the IN cohort was older at transplant (14.56 vs. 11.03 years; p < 0.01), had more time between kidney failure and tran... Pediatric kidney transplant recipients requiring interpreter services for healthcare delivery demonstrate fewer post-transplant interactions with their healthcare team (fewer hospitalizations and more...